Current Perspectives in Epilepsy Treatment: Focus on Monotherapy

	Faculty
		John M. Pellock, MD Professor and Chairman Division of Child Neurology Vice Chairman Department of Neurology VCU Health System Medical College of Virginia Hospitals John M. Pellock, MD, is chairman of the division of child neurology and vice chairman of the department of neurology at the Medical College of Virginia at Virginia Commonwealth University in Richmond, Virginia, where he is also director of the Comprehensive Epilepsy Institute and professor of neurology, pediatrics, and pharmacy and pharmaceutics. He received his MD from St. Louis University, trained in pediatrics at the Medical College of Virginia, and completed a fellowship in child neurology at Columbia-Presbyterian Medical Center in New York. During that fellowship he began working with Dr. C.E. Pippinger to establish pharmacokinetic patterns of antiepileptic drugs in children and adults. His military service at the National Naval Medical Center in Bethesda, Maryland, allowed an interaction with Dr. J. Kiffin Penry, which continued over the years. Dr. Pellock is a diplomat of the American Board of Pediatrics and of the American Board of Psychiatry and Neurology with Special Qualification in Child Neurology. He is a fellow of the American Academy of Neurology and the American Academy of Pediatrics and is a member of several professional organizations, including the American Neurological Association, the American Academy of Neurology, the American Academy of Pediatrics, the Child Neurology Society, and the American Epilepsy Society. He has served as an officer of the CNS, and of the Child Neurology and Epilepsy sections of the AAN, and is currently a member of the Board of Directors of the American Epilepsy Society. Dr. Pellock is senior editor of Pediatric Epilepsy, Diagnosis and Therapy, 2nd Edition, and Neurologic Emergencies in Infancy and Childhood. He is a member of the editorial board of the Journal of Child Neurology, Pediatric Neurology, the Journal of Pediatric Pharmacology and Therapeutics, and the Journal of Epileptic Disorders, and serves as reviewer of a number of journals including Epilepsia, Neurology, Pediatrics, the New England Journal of Medicine, Epilepsy Research, Annals of Neurology, Drug Safety and the Journal of Pediatrics. He has published extensively and lectured widely on pediatric epilepsy and has conducted clinical research in antiepileptic drug development, therapy, adverse events, and clinical epilepsy. He has served on multiple NIH study sections, site visit teams, and oversight committees (NIH and VA).
		Michael D. Privitera, MD Professor and Vice Chair of Neurology University of Cincinnati Medical Center Director Cincinnati Epilepsy Center Dr. Michael Privitera is professor, and vice chair of neurology, University of Cincinnati Medical Center. He is also director of the Cincinnati Epilepsy Center and medical director of UC Physicians (the practice group encompassing the university’s 600 faculty physicians). He has participated in over 50 different research studies sponsored by the National Institutes of Health or the pharmaceutical industry, has authored more than 100 scientific publications and a book on antiepileptic drugs. He has directed the training of 17 postdoctoral fellows. He is on the Board of Directors of the American Epilepsy Society and the Cincinnati branch of the Epilepsy Foundation. He has served as Annual Course director for the American Epilepsy Society and the Epilepsy course director for the American Academy of Neurology.
	Medical Writer
		Sarah Smith
	Disclosure Policy It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors are expected to disclose any relevant financial relationships they may have with commercial interests in relation to this activity. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of ArcMesa Educators. Staff Disclosure Declarations The employees of Scinexa Medical Education Company and ArcMesa Educators have no financial relationships to disclose. Faculty Disclosure Declarations John M. Pellock, MD – Advisory Board, Consultant, Lecturer and Researcher for the following: Abbott Laboratories, Cephalon, Eisai, GlaxoSmithKline, MedPointe, Novartis, OrthoMcNeil, Ovation, Pfizer, Questcor, Schwarz Pharma, UCB Pharma, and Valeant; Consultant and Lecturer for the following: Accorda, AstraZeneca, Aventis, and CoSensys; Advisory Board and Consultant for: Marinus Pharmaceuticals Michael D. Privitera, MD – Research Support – National Institutes of Health, IVAX, Schwarz Pharma, Ortho McNeil, UCB Pharma, The Neuroxcience Institute; Honoraria for Speaking – Glaxo Smith Kline, UCB Pharma, Ortho McNeil, Shire Pharmaceuticals, Janssen-Cilag, Pfizer; Consulting Fees – Ortho McNeil, Pfizer, Glaxo Smith Kline, UCB Pharma, Shire Pharmaceuticals; Foundations – epiFellows Foundations, American Epilepsy Society Sarah Smith – Nothing to Disclose Printer settings may vary. Please use landscape layout option. Copyright © 2006 Scinexa, LLC / CMEdiscovery.com. All rights reserved.